Pharmaceutical freedom : why patients have a right to self-medicate / Jessica Flanigan.
By: Flanigan, Jessica [author.].
Publisher: New York, NY, United States of America : Oxford University Press, [2017]Description: xvii, 263 pages ; 25 cm.Content type: text Media type: unmediated Carrier type: volumeISBN: 9780190684549.Subject(s): Drug accessibility -- Law and legislation -- United States | Pharmaceutical policy -- United States | Medical laws and legislation | Ethics, Clinical | Self Medication | Prescription Drugs | Paternalism | Drug Industry -- ethics | Patient Rights | Drug accessibility -- Law and legislation | Medical laws and legislation | Pharmaceutical policy | United StatesGenre/Form: Print books.| Current location | Call number | Status | Date due | Barcode | Item holds |
|---|---|---|---|---|---|
| On Shelf | RA401.A1 F58 2017 (Browse shelf) | Available | AU00000000012177 |
Browsing Alfaisal University Shelves , Shelving location: On Shelf Close shelf browser
|
|
|
|
|
|
|
||
| RA399.A3 N49 2006 Next steps toward higher quality health care | RA399.G7 .A84 2016 Whistleblowing and ethics in health and social care / | RA399.5 .D85 2013 Pandemics / | RA401.A1 F58 2017 Pharmaceutical freedom : why patients have a right to self-medicate / | RA401.A3 D78 2017 Drug wars : how big pharma raises prices and keeps generics off the market / | RA401.A3 G33 2014 Medical monopoly : intellectual property rights and the origins of the modern pharmaceutical industry / | RA401.A3 H47 2020 White market drugs : big pharma and the hidden history of addiction in America / |
Includes bibliographical references and index.
A defense of self-medication -- Paternalism and public health -- Rethinking prescription requirements -- Responsibility and regulation -- The politics of self-medication -- The business of medicine -- Medical autonomy and modern healthcare -- Conclusion.
Jessica Flanigan defends patients' rights of self-medication on the grounds that same moral reasons against medical paternalism in clinical contexts are also reasons against paternalistic pharmaceutical policies, including prohibitive approval processes and prescription requirements.--